分子式:C11H16N2O2 ,分子量:208.25694,Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2
货号 | 规格 | 数量 | 价格 |
---|---|---|---|
Q-0022413 | 100mg |
1
|
询价 |
Q-0022413 | 250mg |
1
|
询价 |
Q-0022413 | 500mg |
1
|
询价 |
Q-0022413 | 1g |
1
|
询价 |
Q-0022413 | 5g |
1
|
询价 |
参数信息 | |
---|---|
外观状态: | 固体或粉末 |
质量指标: | 95%+ |
溶解条件: | 有机溶剂/水 |
CAS号: | N/A |
分子量: | N/A |
储存条件: | -20℃避光保存 |
储存时间: | 1年 |
运输条件: | 室温2周 |
生产厂家: | 西安齐岳生物科技有限公司 |
-
32487-58-4 3-methoxyfuran-2-carbaldehyde 中间体分子
-
32487-58-4 3-methoxyfuran-2-carbaldehyde 中间体分子
-
分子式:C16H16ClF3N4O2, 分子量:388.77,Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2.
-
分子式: C13H19N3O2 ,分子量: 249.30886,Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2.